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To investigate the molecular basis of oncogenesis induced by the v-jun oncogene of avian sarcoma virus 17 (ASV17), we
developed a conditional cell transformation system in which transcription of the ASV17 v-jun allele is controlled by a
doxycycline-sensitive transactivator (tTA) or a reverse (doxycycline-dependent) transactivator (rtTA), respectively. Permanent
cell lines of quail embryo fibroblasts conditionally transformed by a doxycycline-controlled v-jun allele revert to the normal
phenotype within 3 days and lose their ability to grow in soft agar, strictly dependent on the addition or removal of the drug,
respectively. The reverted cells are rapidly retransformed on conditional activation of v-jun. While full-level synthesis of v-jun
mRNA and v-Jun protein in these cells is established within 2 and 14 h, respectively, after switching to the permissive
conditions, the first morphological alterations are observed after 24 h, and as early as 2 days later the morphology has
changed entirely from flat cells resembling normal fibroblasts to spindle-shaped fusiform cells showing a typical jun-
transformed phenotype. Kinetic expression analysis revealed that transcriptional activation of the direct jun target gene BKJ
precisely coincides with the establishment of full-level v-Jun protein synthesis. Furthermore, we have analyzed the expres-
sion of a novel candidate v-jun target gene, termed JAC, which shows no sequence homology to known genes. Similar to BKJ,
JAC is specifically activated in jun-transformed fibroblasts, and induction of JAC is tightly linked to the conditional expression
of oncogenic v-Jun. These results demonstrate the high stringency of the doxycycline-controlled v-jun expression system,
and they also indicate that expression of v-jun in these cells is indispensable for enhanced proliferation, cell transformation,
and the induction of specific expression patterns of downstream target genes. © 2000 Academic Press
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(INTRODUCTION
One of the prototype oncogenes encoding a transcrip-
tional regulator is jun, originally identified as the onco-
genic determinant of avian sarcoma virus 17 (ASV17)
(Maki et al., 1987). The cellular progenitor of the retroviral
v-jun oncogene, the c-jun protooncogene, encodes a
major component of the AP-1 transcription factor com-
plex, which is composed of dimers derived from mem-
bers of the Jun and Fos protein families (Vogt and Bos,
1990). There is increasing evidence that cellular trans-
formation induced by the v-Jun protein involves the ab-
errant expression of specific genes which are normally
regulated by endogenous c-Jun as a component of AP-1.
So far, several AP-1-responsive genes have been iden-
tified that encode proteins of diverse functions, including
the matrix metalloproteases collagenase and stromely-
sin/transin (Angel et al., 1987; Kerr et al., 1988), the
cytoplasmatic fatty acid-binding protein adipocyte P2
(Rauscher et al., 1988), the heavy metal binding protein
metallothionein IIA (Lee et al., 1987), the Fos-related pro-
tein Fra-1 (Bergers et al., 1995), the noncollagenous bone
rotein osteocalcin (Schu¨le et al., 1990), the cornifiedo1 To whom correspondence and reprint requests should be ad-
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98nvelope precursor proteins involucrin and loricrin
DiSepio et al., 1995; Welter et al., 1995), and the inter-
ediate filament cytokeratins K5 and K18 (Oshima et al.,
990; Casatorres et al., 1994). However, the possible role
f any of those genes in jun-induced cell transformation
as not yet been assessed, and some of them were even
xcluded as relevant targets based on their lack of re-
ponse to a dominant negative Jun mutant protein in a
ouse tumor promotion model (Young et al., 1999).
ence, comprehensive approaches toward the identifi-
ation of functionally significant jun target genes are
andatory to elucidate the molecular mechanisms of
un-induced neoplastic transformation.
Approaches aimed at the identification of genes spe-
ifically dysregulated in jun- or fos-transformed fibro-
lasts have led to the identification of several new po-
ential jun target genes (Hartl and Bister, 1995, 1998;
adman et al., 1996, 1998; Goller et al., 1998; Fu et al.,
999). For two of these genes it has been demonstrated
hat they represent direct transcriptional targets of onco-
enic Jun. The BKJ gene encoding a hydrophobic protein
BKJ) structurally related to avian epidermal b-keratins
as identified based on its strong and highly specific
ctivation in jun- or fos-transformed avian fibroblasts
Hartl and Bister, 1995, 1998). The complete structural
rganization of the BKJ gene was determined by nucle-
otide sequence analysis and transcriptional mapping,
i
i
a
i
(
1
r
o
1
b
d
u
u
a
e
c
t
t
1
c
a
l
y
a
d
f
t
b
t
f
t
e
C
c
o
w
t
c
b
1
1
e
m
p
l
t
o
r
c
A
e
e
o
f
3
t
c
Q
a
f
w
99CONDITIONAL CELL TRANSFORMATION BY v-junand transcriptional transactivation analysis revealed that
BKJ is a direct transcriptional target of the AP-1 compo-
nents Jun and Fos in transformed avian fibroblasts (Hartl
and Bister, 1998). The glutaredoxin gene was found to be
induced in v-jun-transformed fibroblasts and, based on
its activation by a Jun-estrogen receptor chimera (Kruse
et al., 1997) in the presence of the protein synthesis
inhibitor cycloheximide, classified as a direct transcrip-
tional target of Jun (Goller et al., 1998). Another putative
direct target of oncogenic Jun, a gene encoding heparin-
binding epidermal growth factor-like growth factor (HB-
EGF), is distinguished by its capability to induce partial
cell transformation when expressed in a retroviral con-
text (Fu et al., 1999). All of these genes have been
solated from nonconditional transformation systems us-
ng either an established jun-transformed cell line (Hartl
nd Bister, 1995; Hartl et al., 1995) or cells chronically
nfected by a retroviral vector expressing oncogenic Jun
Hadman et al., 1996; Goller et al., 1998; Fu et al., 1999).
Recently, cell transformation systems have been de-
veloped that are based on the conditional expression of
oncogenic DNA-interacting transcriptional regulators.
These conditional systems, following two different prin-
cipal strategies, should greatly facilitate the search for
target genes, since they allow temporal and quantitative
control of oncogene expression and a detailed kinetic
analysis of subsequent target gene dysregulation. One
strategy employs the synthesis of a hybrid protein en-
compassing the oncoprotein and the ligand-binding do-
main of steroid hormone receptors, leading to a chimeric
protein whose oncogenic function is ligand dependent.
This approach has been applied to generate hormone-
dependent receptor chimera of retroviral transforming
proteins like the MC29 v-Myc protein (Tikhonenko et al.,
995) or the ASV17 v-Jun protein (Kruse et al., 1997),
allowing hormone-dependent Myc or Jun regulation at
the protein level. A second strategy employs prokaryotic
regulatory protein domains and cis-acting control ele-
ments of the tetracycline-resistance operon of Esche-
ichia coli to regulate transcription of the eukaryotic gene
f interest (Gossen and Bujard, 1992; Gossen et al., 1993,
995). Tetracycline-controlled transactivators generated
y fusion of the tet repressor with the transactivating
omain of the herpes simplex virus VP16 protein were
sed to activate transcription of the relevant gene placed
nder control of a minimal promoter linked to tet operator
sequences. Transactivators that are active only in the
absence or in the presence of tetracycline or its deriva-
tives were engineered, allowing differential transcrip-
tional control of the gene of interest by the addition or
removal of the drug (Gossen and Bujard, 1992; Gossen et
l., 1995). Based on the latter strategy, we have recently
stablished a doxycycline-controlled, tightly regulatable
onditional transformation system, which allows precise
emporal and quantitative control of v-myc expression athe transcriptional level in avian fibroblasts (Oberst et al.,
999).
Here we describe the generation of a doxycycline-
ontrolled expression system for the ASV17 v-jun allele
nd the establishment of conditionally v-jun-transformed
ong-term avian fibroblast lines. We show a kinetic anal-
sis of the transcriptional induction of BKJ on conditional
ctivation of v-jun, and we use this system to analyze the
ifferential expression of JAC, a novel gene of unknown
unction presumably representing a direct transcriptional
arget of Jun. The conditional jun transformation system
ased on transcriptional control of v-jun will be a useful
ool to elucidate the downstream effects in v-jun-induced
ibroblast transformation and to provide more insight into
he biochemical function of Jun and its role in oncogen-
sis.
RESULTS
onditional cell transformation by doxycycline-
ontrolled v-jun expression
To establish long-term cell lines that express the v-jun
ncogene under the control of the transactivator tTA,
hich binds to tet operator sequences and activates
ranscription only in the absence of doxycycline, two
onstructs were cotransfected into quail embryo fibro-
lasts (QEF) in the absence of doxycycline: pUHD15-
neo, constitutively expressing tTA (Gossen and Bujard,
992; Resnitzky et al., 1994) (Fig. 1); and pUHD10-3VJ1,
xpressing the ASV17 v-jun allele under control of a
inimal cytomegalovirus promoter fused to seven re-
eats of tet operator sequences (Fig. 1). To establish cell
ines that express v-jun under the control of the reverse-
ransactivator rtTA, which is active only in the presence
f doxycycline, pUHD17-1neo constitutively expressing
tTA (Gossen et al., 1995) (Fig. 1) and pUHD10-3VJ1 were
otransfected into QEF in the presence of doxycycline.
fter 2 to 3 weeks under agar overlay, single-cell foci
merged from independent v-jun-induced transformation
vents. In total, 142 foci derived from the cotransfection
f pUHD15-1neo and pUHD10-3VJ1, and 27 foci derived
rom the cotransfection of pUHD17-1neo and pUHD10-
VJ1 were isolated and propagated. One cell clone con-
aining the tTA transactivator (Q/35) and three clones
ontaining the rtTA transactivator (Q/VII, Q/XXII, and
/d3) could be cultured for more than 3 months and were
nalyzed further. These clones have now been passaged
or more than 1 year and can be frozen and rethawed
ithout loss of viability.
To examine whether these cell lines express v-jun in a
doxycycline-regulatable manner, transformed cells of the
four immortalized clones were grown in the absence or
in the presence of doxycycline for 6 days. The Northern
analysis shown in Fig. 2A revealed that the 1.4-kb v-jun
mRNA encoded by pUHD10-3VJ1 was present in cells
containing a tTA-dependent v-jun allele (Q/35) only in the
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100 BADER, HARTL, AND BISTERabsence of doxycycline, and in cells containing the rtTA-
dependent v-jun allele (Q/VII, Q/XXII, Q/d3) only in the
presence of doxycycline. The amount of v-jun mRNA in
hese conditionally transformed cell lines was compara-
le to the amount of each of the genomic and sub-
enomic retroviral jun-specific RNA species (8.5 kb, gag-
ol-env-jun; 4.3 kb, env-jun; and 2.0 kb, jun) present in the
CD cell line transformed by the retroviral construct
CAS-VCD (Hartl et al., 1995). The 2.0-kb c-jun mRNA
as detectable in normal QEF and, at lower levels, in the
onditionally transformed cell lines under nonpermissive
onditions leading to reverted, nontransformed cells (see
elow), but was completely suppressed under permis-
ive conditions leading to transformed cells (Fig. 2A).
his is in agreement with previous reports on the auto-
egulatory suppression of endogenous c-jun or c-myc
enes by exogenous deregulated jun or myc alleles
Penn et al., 1990; Gao et al., 1996; Hartl and Bister, 1998;
Oberst et al., 1999).
We have recently identified the BKJ gene as a direct
ranscriptional target of AP-1 (Hartl and Bister, 1995,
FIG. 1. Schematic diagram of the plasmids used to generate a dox
cytomegalovirus immediate-early gene 1 promoter/enhancer (PhCMV),
containing the tet repressor from Escherichia coli or a mutant derivative
herpes simplex virus (Gossen and Bujard, 1992; Gossen et al., 1995).
absence of doxycycline, whereas rtTA binds to the tet operator sequ
indicates neomycin resistance gene; Ampr, ampicillin resistance ge
olyadenylation signal. The response plasmid pUHD10-3VJ1 contains
f the tet operator O2 of the Tn10-specified tetracycline resistance o
(Gossen and Bujard, 1992), and an insertion of the ASV17 v-jun coding
and Bister, 1995).998). BKJ is a novel gene related to the b-keratin gene
family, and its expression is strongly and specificallyinduced in avian embryo fibroblasts transformed by
the jun or fos oncogenes. Promoter analysis revealed
that the BKJ gene is activated by a direct interaction of
the AP-1 components Jun and Fos with an authentic
AP-1 DNA binding site located upstream of the major
transcription initiation site (Hartl and Bister, 1998).
Furthermore, using a conditional jun-transformation
system based on activation of a Jun/hormone receptor
chimera at the protein level, it was shown that BKJ is
activated in this system even in the presence of the
protein synthesis inhibitor cycloheximide, supporting
the view that BKJ is a direct transcriptional target of
Jun (Kruse et al., 1997). It was therefore of great inter-
est to test the induction of BKJ in the conditional
transformation system developed here, in which v-jun
expression is tightly regulated at the transcriptional
level, leading to expression of an authentic Jun pro-
tein. As shown in Fig. 2A, the BKJ expression pattern in
cells conditionally transformed by v-jun precisely cor-
relates with that of the doxycycline-regulatable v-jun
allele, demonstrating the close molecular connection
-controlled v-jun expression system. Under the control of the human
5-1neo and pUHD17-1neo encode transactivator proteins (tTA, rtTA)
f (reverse repressor) fused to the transactivation domain of VP16 from
ds to tet operator sequences and activates transcription only in the
nd activates transcription only in the presence of doxycycline. Neor
lE1 ori, E. coli origin of replication; and SV40 An, simian virus 40
TA-dependent promoter (PhCMV*-1) constructed by fusing seven repeats
from E. coli to the human cytomegalovirus minimal promoter (PhCMV*)
derived from the retroviral construct RCAS-VJ1 (Bos et al., 1990; Hartlycycline
pUHD1
thereo
tTA bin
ences a
ne; co
a tTA/rt
peronbetween the transactivator protein Jun and the tran-
scriptional target BKJ. No BKJ expression was detected
t
g
t
c
a
indicated cell sources. Cell extracts for protein analysis were prepared
in parallel with the RNA extracts used for the Northern analysis shown
101CONDITIONAL CELL TRANSFORMATION BY v-junin the reverted cell populations (nonpermissive condi-
tions). The tightness of differential expression of BKJ in
he conditional cell transformation system is indistin-
uishable from that observed for BKJ expression in
jun-transformed VCD cells versus normal QEF (Fig.
2A). In the conditional transformation system, the level
of GAPDH mRNA was generally higher under permis-
sive (transforming) conditions than under nonpermis-
sive (reverting) conditions (Fig. 2A). A similar reduction
of the expression of this glycolytic enzyme gene has
been described for the reverted cells in a conditional
v-myc transformation system (Oberst et al., 1999), and
this may be due to the lower proliferative and meta-
bolic rates of these cells.
Using protein extracts from the same cells that were
analyzed by Northern hybridization in Fig. 2A, an immu-
noblot analysis (Fig. 2B) revealed that the v-Jun protein
with the expected apparent molecular weight of 36,000
(Hartl and Bister, 1998) was present at high amounts in
cells containing the tTA-dependent v-jun allele (Q/35)
only in the absence of doxycycline, and in cells contain-
ing the rtTA-dependent v-jun allele (Q/VII, Q/XXII, Q/d3)
only in the presence of doxycycline. The amount of v-Jun
in these cells is comparable to that of the 45-kD chimeric
Jun protein in transformed VCD cells (Hartl et al., 1995)
(Fig. 2B). In agreement with the RNA analysis in Fig. 2A,
the expression of the 42-kD c-Jun protein (Bos et al.,
1990; Hartl et al., 1995; Hartl and Bister, 1998) was de-
tectable only at typically low levels in reverted cells or in
normal QEF.
Cellular and molecular events following v-jun
suppression or reexpression
As a major advantage, tight conditional expression
systems employing regulation at the transcriptional
level facilitate not only quantitative but also precise
temporal control of gene expression (Oberst et al.,
1999). Figure 3 shows an analysis of the time course of
v-jun suppression and reexpression following removal
and readdition of doxycycline in Q/d3 cells containing
the rtTA-dependent v-jun allele. Doxycycline was re-
moved from transformed Q/d3 cells for 6 days. Then,
doxycycline was readded to the reverted cells, and the
cells were incubated in the presence of the drug for 1,
2, 4, 7, and 14 h, and for 1, 2, 3, and 7 days. Total RNAs
in (A). Proteins from equal numbers of cells (1.25 3 105) were analyzed
by SDS–polyacrylamide (10% w/v) gel electrophoresis and immunoblot-
ting using a polyclonal antiserum directed against recombinant c-Jun
protein. The positions of the 36-kD v-Jun protein encoded by pUHD10-
3VJ1, of the 45-kD chimeric Jun protein encoded by RCAS-VCD, and of
molecular weight markers (Sigma) are indicated in the margin. The
42-kD quail c-Jun protein expressed at low levels in all nontransformedFIG. 2. Conditional cell transformation by v-jun. pUHD15-1neo and
pUHD10-3VJ1, or pUHD17-1neo and pUHD10-3VJ1, were cotransfected
into quail embryo fibroblasts (QEF). Morphologically transformed cell
clones selected by focus formation were isolated after 2 weeks and
propagated in culture. Several cell clones survived for more than 3
months and developed into lines. The cell line Q/35, which was derived
by cotransfection of pUHD15-1neo and pUHD10-3VJ1, was continuously
grown in the absence of doxycycline (2) or in the presence of doxy-
cycline for 6 days (1). Cell lines Q/VII, Q/XXII, and Q/d3, which were
derived by cotransfection of pUHD17-1neo and pUHD10-3VJ1, were
continuously grown in the presence of doxycycline (1) or in the ab-
sence of doxycycline for 6 days (2). Normal QEF and cells from the
quail fibroblast line VCD transformed by the chimeric jun allele of the
RCAS-VCD retroviral construct (Hartl et al., 1995) were used as controls.
(A) Northern analysis of equal amounts (2 mg) of poly(A)1 RNAs from
he indicated cell sources. The filter was successively hybridized with
32P-labeled DNA probes using a fragment derived from the chicken
-jun coding region (7.5 3 107 cpm) (top panel), the insert fragment of
quail cDNA clone (4.8 3 107 cpm) derived from the BKJ gene, a direct
transcriptional target of v-Jun (Hartl and Bister, 1995, 1998) (middle
panel), and the insert fragment of a quail GAPDH cDNA clone (6.0 3
107 cpm) (bottom panel). Autoradiograms were exposed for 46, 23, and
144 h, respectively, using an intensifying screen. The sizes of c-jun
mRNA, of v-jun mRNA specified by pUHD10-3VJ1, of BKJ mRNA, and of
GAPDH mRNA were 2.0, 1.4, 0.8, and 1.4 kb, respectively. The sizes of
the genomic and subgenomic mRNAs of the RCAS-VCD retrovirus were
8.5, 4.3, and 2.0 kb, respectively. The positions of 28S and 18S ribo-
somal RNAs with sizes of 4.3 and 1.9 kb, respectively, are indicated in
the margin (top panel). (B) Immunoblot analysis of proteins from thecells is visible on the original immunoblot but not in the photographic
reproduction.
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102 BADER, HARTL, AND BISTERand proteins were extracted at each time point and
analyzed by Northern hybridization and immunoblot-
ting. Equal loading of RNAs and proteins on gels was
confirmed by ethidium bromide staining of RNA and
Ponceau S staining of blotted proteins, respectively.
Reactivation of v-jun mRNA is detectable as soon as
h after the addition of doxycycline to the culture
edium, and after 2 h, v-jun expression is almost
ompletely restored to the level observed immediately
efore removal of the drug at day 26 (Fig. 3A). Bio-
ynthesis of the v-Jun protein is first detected 4 h after
eaddition of the drug, and protein expression is fully
estored after 14 h (Fig. 3B). The expression kinetics of
he BKJ gene following v-jun induction were also ana-
yzed. Expression of BKJ mRNA in Q/d3 cells was first
etectable 14 h after readdition of doxycycline (Fig.
FIG. 3. Kinetics of doxycycline-controlled transcriptional regulation o
KJ gene, a direct transcriptional target of the v-Jun protein (Hartl and B
dish and were not transferred during the time course. At day 26, t
continuously in the presence of doxycycline were depleted of the drug
reverted cells (day 0), and cell culturing was continued. (A) Northern an
Cells from parallel dishes were extracted at the time points indicated. N
probe (5.5 3 107 cpm) derived from the chicken c-jun coding region, an
ow-level expression of endogenous c-jun in the nontransformed cel
uccessively with the 32P-labeled insert fragment of a quail BKJ cDNA c
APDH cDNA clone (5.0 3 107 cpm; 120-h exposure). The positions o
analysis of cell extracts from the indicated sources is shown. Cell extra
for the Northern analysis shown in (A). Proteins from equal numbers
lectrophoresis and immunoblotting using a polyclonal antiserum direc
ncoded by pUHD10-3VJ1 is indicated in the margin. The 42-kD quail c
he original immunoblot but not in the photographic reproduction.A), precisely coinciding with full reexpression of the
-Jun protein (Fig. 3B). After 3 days, BKJ expression
s
owas completely restored to the level observed imme-
diately before removal of the drug at day 26 (Fig. 3A).
To monitor the changes in cell morphology in the
onditional jun-transformation system, the cell lines Q/35
(Figs. 4A and 4B) and Q/d3 (Figs. 4C and 4D) containing
a tTA-dependent v-jun allele or a rtTA-dependent v-jun
llele, respectively, were grown for 6 days in the absence
Figs. 4A and 4C) or in the presence of doxycycline (Figs.
B and 4D). Under permissive conditions (Figs. 4A and
D), the cell morphology resembles that of the noncon-
itionally jun-transformed cell line VCD (Figs. 4E and 4F),
nd under nonpermissive conditions (Figs. 4B and 4C) it
esembles that of normal QEF (Figs. 4G and 4H), al-
hough the reverted cells are generally larger than nor-
al QEF. The nonconditionally jun-transformed VCD
ells (Figs. 4E and 4F) or normal QEF (Figs. 4G and 4H)
n Q/d3 cells and of the tightly coupled transcriptional regulation of the
95, 1998). Cells were seeded at a density of 6 3 106 cells per 100-mm
med Q/d3 cells containing a rtTA-dependent v-jun allele and grown
days of incubation without doxycycline, the drug was readded to the
f equal amounts (15 mg) of total RNAs from the indicated cell sources.
QEF were used as control. The filter was hybridized with a 32P-labeled
utoradiograph was exposed for 23 h using an intensifying screen. The
ig. 2A) is visible only on longer exposures. The filter was reprobed
.8 3 107 cpm; 6.5-h exposure), and with the insert fragment of a quail
mal RNAs are indicated in the margin (top panel). (B) An immunoblot
protein analysis were prepared in parallel with the RNA extracts used
ls (1.25 3 105) were analyzed by SDS–polyacrylamide (10% w/v) gel
inst recombinant chicken c-Jun. The position of the 36-kD v-Jun protein
otein expressed at low levels in all nontransformed cells is visible onf v-jun i
ister, 19
ransfor
. After 6
alysis o
ormal
d the a
ls (cf. F
lone (4
f riboso
cts for
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ted agahow no significant morphological response to addition
r removal of doxycycline.
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103CONDITIONAL CELL TRANSFORMATION BY v-junDependence of transformation parameters on v-jun
expression
Transformed Q/35 cells grow with doubling times of
4.2 days and reach densities of 5.0 3 106 cells per
5-mm dish (Fig. 5A). Transformed Q/d3 cells grow more
apidly with doubling times of 1.7 days and reach densi-
ies of up to 7.5 3 106 cells per 35-mm dish (Fig. 5B),
lmost comparable to the growth rate of the established
onconditionally jun-transformed VCD cell line with a
oubling time of 1.3 days and a maximal cell density of
6
FIG. 4. Doxycycline-dependent morphological changes of Q/35 and
Q/d3 (C and D) containing a tTA-dependent v-jun allele or a rtTA-depen
VCD (E and F), and of normal QEF (G and H) are shown. Cells were g
doxycycline for six days. The magnification is indicated by the bar..0 3 10 per 35-mm dish (Fig. 5C). To test whether the
onditionally transformed cell lines require v-jun expres-
p
sion to maintain the observed proliferation rates, the
rowth properties of Q/35, Q/d3, and control VCD cells
ere compared in the presence or in the absence of
oxycycline. Suppression of v-jun by addition of doxycy-
line to Q/35 cells, or by removal of doxycycline from
/d3 cells, resulted in withdrawal from the cell cycle
Figs. 5A and 5B). When doxycycline was readded to a
/d3 culture 7 days after v-jun suppression, the cells
eentered the cell cycle and reached a final cell density
quivalent to that of Q/d3 cells grown continuously in the
ells. Phase-contrast micrographs of the cell lines Q/35 (A and B) and
un allele, respectively, of the nonconditionally jun-transformed cell line
n the absence (A, C, E, and G) or in the presence (B, D, F, and H) ofQ/d3 c
dent v-jresence of doxycycline (Fig. 5B). Control VCD cells
howed equal proliferation rates in the presence or ab-
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104 BADER, HARTL, AND BISTERsence of doxycycline (Fig. 5C). These data suggest that
v-jun expression is sufficient to stimulate cell-cycle re-
entry in quiescent cells, and that its continuous expres-
FIG. 5. Growth rates of conditionally and nonconditionally v-jun-
transformed cell lines. The average numbers of cells from three parallel
dishes were determined at the indicated time points, and the culture
medium was renewed every 2 days. (A) Growth properties of Q/35 cells
containing a tTA-dependent v-jun allele. Cells were seeded at a density
of 1.5 3 106 cells per 35-mm dish in the absence of doxycycline. The
ext day, one half of the dishes remained in doxycycline-free medium
), whereas doxycycline was added to the other half of the dishes (n ).
B) Growth properties of Q/d3 cells containing a rtTA-dependent v-jun
llele grown in the presence (n ) or absence () of doxycycline. Cells
ere seeded at a density of 1.0 3 106 cells per 35-mm dish in medium
ontaining doxycycline. The next day, doxycycline was removed from
wo thirds of the dishes. After 7 days the drug was readded to one half
f the doxycycline-depleted dishes (F). (C) Nonconditionally jun-trans-
ormed VCD cells were seeded at a density of 1.5 3 106 cells per 35-mm
dish in medium without doxycycline. The next day, one half of the
dishes remained in doxycycline-free medium (), whereas doxycycline
was added to the other half of the dishes (n ).sion is necessary for the proliferation of jun-transformed
cells.
(
nTo test whether the conditionally transformed cells are
capable of anchorage-independent growth and whether
this property is strictly dependent on v-jun expression,
transformed Q/35 and Q/d3 cells were seeded in soft
agar in the presence or absence of doxycycline (Table 1).
After 2 to 3 weeks in doxycycline-free soft agar, Q/35
cells (Table 1, Fig. 6A) produced agar colonies that were
similar in size and morphology to those produced by
cells from the established nonconditionally jun-trans-
formed cell line VCD in the presence or in the absence of
doxycycline (Table 1, Figs. 6E and 6F). In the presence of
doxycycline, Q/35 cells produced no agar colonies (Table
1, Fig. 6B). Q/d3 cells produced agar colonies in the
presence of doxycycline (Table 1, Fig. 6D), but not in its
absence (Table 1, Fig. 6C), and normal QEF produced no
colonies in the presence or absence of doxycycline
(Figs. 6G and 6H). In summary, all molecular and cellular
parameters of transformation tested for cells condition-
ally transformed by v-jun are strictly dependent on the
expression of v-jun, including expression of the AP-1
target gene BKJ, cell morphology, enhanced proliferation,
and anchorage-independent growth.
Differential expression of JAC in conditionally
v-jun-transformed fibroblasts
Using subtractive hybridization techniques, we have
recently isolated a novel gene specifically activated in
ASV17-transformed chicken embryo fibroblasts (CEF).
The 622-bp cDNA sequence of this gene, termed JAC (for
un-activated gene in CEF), encodes a 68-amino acid
rotein with no homology to known sequences in the
ata bases (data not shown). To test if this new candi-
TABLE 1
Conditional and Nonconditional Colony Formation
by v-jun-Transformed Avian Fibroblasts
Cells
Colony formation in soft agara
2 Doxycycline 1 Doxycycline
Colonies/cells
seeded Percentage
Colonies/cells
seeded Percentage
Q/35 2,025/50,000 4.1 0/50,000 0.0
Q/VII 28/50,000 0.06 4,884/50,000 9.8
Q/XXII 37/50,000 0.07 3,259/50,000 6.5
Q/d3 0/50,000 0.0 2,395/50,000 4.8
VCD 3,665/50,000 7.3 4,791/50,000 9.6
QEF 0/50,000 0.0 0/50,000 0.0
a Soft agar colony assays of the cell line Q/35 containing a tTA-
ependent v-jun allele, of the cell lines Q/VII, Q/XXII, and Q/d3 contain-
ng a rtTA-dependent v-jun allele, of the established jun-transformed
uail cell line VCD (Hartl et al., 1995), or of normal quail embryo
ibroblasts (QEF) were carried out according to published procedures
Bister et al., 1977) in the presence or absence of doxycycline. Colony
umbers from two to four independent experiments were averaged.
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105CONDITIONAL CELL TRANSFORMATION BY v-jundate jun target gene would respond in the conditional
transformation system, the expression of JAC in condi-
tionally transformed Q/35 and Q/VII cells containing a
tTA-dependent v-jun allele or a rtTA-dependent v-jun al-
lele, respectively, was analyzed by Northern blotting (Fig.
7). RNA was extracted from transformed or reverted Q/35
and Q/VII cells grown in the absence or for 6 days in the
presence of doxycycline, or vice versa. RNAs from nor-
mal QEF, from QEF transfected by the empty retroviral
RCAS vector, from QEF transformed by RCAS-VJ1 or
RCAS-MC29, carrying a v-jun or a v-myc allele, respec-
ively, and from cell lines transformed by the v-myc/v-mil
MH2A-10), the v-myc (MH2D12), the v-myc (Q8), or the
-src [R(2)3] oncogenes, or by a chemical carcinogen
QT6) were used as controls. Hybridization with a DNA
ragment derived from a quail cDNA clone homologous
o chicken JAC revealed that transcription of this gene is
FIG. 6. Conditional agar colony formation by Q/35 and Q/d3 cells.
Equal numbers of cells (1 3 105) from the Q/35 cell line containing a
tTA-dependent v-jun allele (A and B), from the Q/d3 cell line containing
a rtTA-dependent v-jun allele (C and D), from the nonconditionally
jun-transformed cell line VCD (E and F), or from normal QEF (G and H)
were seeded in soft agar on 35-mm dishes in the absence (A, C, E, and
G) or in the presence (B, D, F and H) of doxycycline. Bright-field
micrographs were taken after 17 days. The magnification is indicated
by the bar.pecifically activated in cells conditionally (Q/35 and
/VII) or nonconditionally (RCAS-VJ1) transformed by
G
m-jun, but not in cells transformed by oncogenic agents
ifferent from jun (Fig. 7). In the conditional system, JAC
ctivation is strictly dependent on the permissive condi-
ions, with higher levels of expression in Q/35 than in
/VII (Fig. 7). Hybridization of the same RNAs with a BKJ
NA probe revealed that the jun-dependent expression
atterns of JAC and BKJ are qualitatively identical and
that JAC, like BKJ (Hartl and Bister, 1995, 1998), may
FIG. 7. Transcriptional activation of JAC and BKJ in conditionally and
nonconditionally jun-transformed quail embryo fibroblasts. Northern
analysis of equal amounts (5 mg) of poly(A)1 RNAs from normal QEF,
rom QEF transfected with the empty retroviral RCAS vector, from QEF
ransfected with the retroviral construct RCAS-VJ1 encoding v-Jun (Hartl
nd Bister, 1995), and from the quail fibroblast lines Q/35 and Q/VII
ontaining a v-jun allele dependent on a doxycycline-sensitive trans-
ctivator (tTA) or a reverse transactivator (rtTA), respectively, grown in
he absence (2) or for 6 days in the presence (1) of doxycycline, or vice
ersa. Equal amounts (5 mg) of poly(A)1 RNAs from the quail fibroblast
lines MH2A10 (transformed by MH2 v-myc and v-mil) (Jansen et al.,
1983), MH2D12 (transformed by MH2 v-myc) (Jansen et al., 1985), Q8
(transformed by MC29 v-myc) (Bister et al., 1977), RCAS-MC29 (trans-
formed by MC29 v-myc) (Tikhonenko and Linial, 1992), QT6 (derived
from a methylcholanthrene-induced fibrosarcoma) (Moscovici et al.,
1977), and R(2)3 (transformed by RSV v-src) (Bister et al., 1977) were
used as controls. The filter was successively hybridized with 32P-
abeled quail cDNA probes derived from the novel putative jun target
ene JAC (6.9 3 107 cpm, 49-h exposure; top panel), from the estab-
ished jun target gene BKJ (4.6 3 107 cpm, 4-h exposure; middle panel),
and from GAPDH (5.6 3 107 cpm, 25-h exposure; bottom panel),
respectively. The sizes of the mRNAs are: JAC, 0.8 kb; BKJ, 0.8 kb; andAPDH, 1.4 kb. The positions of ribosomal RNAs are indicated in the
argin (top panel).
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106 BADER, HARTL, AND BISTERrepresent a direct transcriptional target of oncogenic Jun.
Hybridization with GAPDH revealed that the expression
f this housekeeping gene was slightly reduced in the
everted Q/35 and Q/VII cells grown in the presence or in
he absence of doxycycline, respectively (cf. Fig. 2A).
DISCUSSION
Conditionally transformation-defective mutants of
ous sarcoma virus carrying a mutant v-src oncogene
ncoding a temperature-sensitive v-Src protein have
layed a seminal role in establishing the oncogene con-
ept and in elucidating the basic molecular mechanisms
f cell transformation (Martin, 1970; Hanafusa, 1977;
ogt, 1977). Analogous mutants of oncogenic avian ret-
oviruses carrying oncogenes encoding nuclear proteins
ike Myc or Jun (Bister and Jansen, 1986; Vogt and Bos,
990) could not be isolated, possibly because these
roteins are regulatory DNA-interacting proteins and not
nzymes like the protein kinase Src. The lack of such
utants has severely hindered investigations into the
olecular mechanisms of cell transformation and tumor
nduction by myc or jun, in particular the search for
ownstream targets of these oncogenes. The recent
evelopment of tetracycline-controlled transactivation
ystems for inducible gene expression has greatly facil-
tated the temporal and quantitative control of exogenous
enes in animal cells, and allowed new approaches
oward the elucidation of the downstream effects of con-
rolled changes in gene expression (Shockett and
chatz, 1996). These systems are based on two principal
omponents: (1) transcriptional transactivators that inter-
ct specifically with cis-acting prokaryotic control ele-
ents placed upstream of the eukaryotic gene of inter-
st, and (2) antibiotics that modulate the binding of the
ransactivators to such elements at low, nontoxic con-
entrations. Compared with other approaches of condi-
ional gene expression, the main advantages of the tet-
acycline-controlled systems are the absence of nonspe-
ific pleiotropic effects of the drugs used to control the
xpression system, the tightness of transcriptional con-
rol allowing virtual on/off regulation of genes, and the
reservation of the authentic gene product, with no need
or structural changes, like fusion with heterologous pro-
ein domains. Such structural changes, like fusion with a
ormone receptor domain, may lead to functional alter-
tions of the original gene product (Mol et al., 1995), and
roteolytic processing of chimeric constructs may re-
ease the protein of interest from hormonal control and
ause leakiness of the system (Kruse et al., 1997).
We have recently succeeded in generating a doxycy-
line-controlled expression system of the MC29 v-myc
llele and in establishing long-term QEF lines condition-
lly transformed by v-myc (Oberst et al., 1999). Here we
escribe the generation of an analogous system for the
onditional expression of the ASV17 v-jun allele. Again,
i
aEF were chosen for the establishment of permanent
ell cultures because these cells are more suitable for
mmortalization than transformed CEF (Bister et al., 1977;
artl et al., 1995). Several of the jun-transformed cell
lones overcame cell crisis after repeated passaging
nd developed into long-term cell cultures still displaying
he ability to express the transforming v-jun allele in a
trictly doxycycline-controlled manner. Molecular analy-
es of v-jun mRNA and protein expression in these cells
evealed that the control of gene expression by addition
r removal of doxycycline is rapid and, most important,
ompletely tight. The cellular parameters of transforma-
ion, like morphological alterations, anchorage-indepen-
ent growth, and enhanced proliferation, are all depen-
ent on continuous v-jun expression, and are fully re-
ersible following repression or reexpression,
espectively, of the inducible v-jun allele. When kept in
the permissive state, these cells display a typical fusi-
form morphology similar to the nonconditionally jun-
transformed cell line VCD (Hartl et al., 1995) and grow to
high cell densities. Interestingly, the morphological alter-
ations typical for v-jun-transformed or reverted cells, re-
spectively, occur with a significant delay after activation
or repression of the v-jun oncogene at the transcriptional
and, subsequently, the translational level. Similar delays
of morphological alterations were also observed in con-
ditional transformation systems employing regulatable
c-fos or v-myc alleles (Miao and Curran, 1994; Oberst et
l., 1999), probably resulting from an unknown number of
olecular processes downstream of the initiating acti-
ation or suppression events that are necessary for es-
ablishing the pleiotropic alterations of cellular morphol-
gy and growth properties. Furthermore, the differential
tability of intermediate protein effectors may contribute
o the delay in cellular response to changes in oncogene
xpression.
A characteristic feature of the conditional cell trans-
ormation system established here is the nearly com-
lete withdrawal of rapidly growing transformed cells
rom the cell cycle after repression of the regulatable
-jun allele and subsequent morphological reversion,
espite the continued presence of serum growth factors.
he observation of cell-cycle exit after oncogene inacti-
ation is in agreement with similar observations reported
or conditional cell-transformation systems employing a
egulatable v-myc allele (Oberst et al., 1999), a Myc-
glucocorticoid receptor chimera (Tikhonenko et al.,
995), or a temperature-sensitive v-Src protein (Johnson
t al., 1998). This may be due to growth inhibitory effects
f disturbed cytoskeletal structures and cell adhesions in
he transformed cells that are compatible with cell
rowth only in the presence of the active oncogene
rotein product, and that are restored to normal only
ncompletely or with a significant delay after removal or
nactivation of the oncogene protein product (Johnson et
l., 1998). Intriguingly, reactivation of the regulatable
107CONDITIONAL CELL TRANSFORMATION BY v-junv-jun allele in the resting cells, like reactivation of regu-
latable v-myc in such cells (Oberst et al., 1999), allows
full restoration of the transformed phenotype, including
all cellular and molecular parameters tested, indicating
that expression of v-jun is sufficient to induce reentry of
the cell cycle and full restoration of the transformed state
including rapid cell growth. In summary, the results ob-
tained here using doxycycline-controlled expression of
v-jun demonstrate conclusively that continuous expres-
sion of v-jun is required for the maintenance of the
transformed phenotype including enhanced cell prolifer-
ation. Recently, a doxycycline-controlled expression sys-
tem for oncogenic H-Ras was used to demonstrate that
continuous expression of this oncoprotein is required for
tumor maintenance in a mouse melanoma model (Chin
et al., 1999).
The identification of the downstream targets of onco-
genic transcription factors like Jun and the rigorous proof
that such direct or indirect target genes are necessary or
even sufficient mediators of the biological function of
these proteins, have proved difficult. Cell transformation
by such proteins apparently involves changes in the
expression patterns of multiple genes, and may even
depend on multiple interactions in the transcription fac-
tor network. The conditional jun expression and cell
transformation system described here provides a valu-
able tool to facilitate the isolation and characterization of
such target genes. The advantage of this system, allow-
ing precise quantitative and temporal control of v-jun
expression and subsequent target gene induction, is
evident from the detailed analysis of BKJ expression in
these cells. In all clones of conditionally v-jun-trans-
formed QEF, the transcriptional activation of BKJ is strictly
dependent on the permissive conditions, i.e., conditions
allowing expression of v-jun mRNA and its protein prod-
uct and, subsequently, cell transformation. Furthermore,
kinetic analyses show that transcriptional activation of
BKJ occurs shortly after v-jun mRNA induction and pre-
cisely coincides with the establishment of full-level v-Jun
protein synthesis. This directly demonstrates the close
functional link between the Jun transactivator protein and
its transcriptional target BKJ. It was recently demon-
strated that the biochemical function of transactivation
by the AP-1 transcription factor complex is required for
carcinogenesis in vivo (Young et al., 1999). Hence, the
strict qualitative and temporal correlation between jun
activation and transactivation of BKJ not only demon-
strates the usefulness of the tight conditional transfor-
mation system, but may also indicate a possible role of
BKJ in jun-induced fibroblast transformation.
The conditional cell-transformation system estab-
lished here was also used to analyze the expression
pattern of a novel candidate jun target gene, termed JAC.
JAC was isolated by subtractive hybridization using RNA/
cDNA preparations from normal versus ASV17-trans-
formed CEF. In all clones of conditionally v-jun-trans-formed QEF tested, the transcriptional activation of JAC,
like that of BKJ, is strictly dependent on the permissive
conditions. Transcriptional activation of JAC is also ob-
served in nonconditionally v-jun-transformed avian fibro-
blasts and even in jun-induced fibrosarcomas in vivo (M.
Hartl and K. Bister, unpublished data). In summary, these
data strongly suggest that JAC represents a direct tran-
scriptional target of Jun that may be directly involved in
jun-induced oncogenesis. Interestingly, the cDNA se-
quence of JAC and the amino acid sequence of its de-
duced protein product show no similarity to database
sequence entries. Isolation and structural analysis of the
JAC gene locus, promoter transactivation studies, and
transcriptional mapping will be required to unambigu-
ously define JAC as a direct transcriptional target of Jun,
and definition of the biochemical function of the JAC
protein product will be necessary to assess its putative
role in jun-induced oncogenesis. The availability of per-
manent cell lines conditionally transformed by a doxycy-
cline-controlled v-jun allele will considerably facilitate
the isolation and characterization of further jun target
genes, particularly of direct transcriptional targets of Jun.
The tight and immediate response of the regulatable
v-jun allele to addition or removal of the drug will even
allow screening for genes that may be only transiently
dysregulated during the switch between the permissive
and the nonpermissive conditions, and yet may be im-
portant mediators of jun-induced cell transformation.
MATERIALS AND METHODS
Plasmids and DNA cloning
The plasmids pUHD15-1neo, pUHD17-1neo, and
pUHD10-3, which constitute the inducible expression
system, were kindly provided by Hermann Bujard (Center
for Molecular Biology, Heidelberg, Germany) (Gossen
and Bujard, 1992; Resnitzky et al., 1994; Gossen et al.,
1995). pUHD15-1neo contains the tTA transactivator
gene, pUHD17-1neo the rtTA reverse transactivator gene
under the control of the human cytomegalovirus imme-
diate-early gene 1 promoter/enhancer. Plasmid
pUHD10-3 contains seven repeats of the tet operator O2
of the Tn10-specified tetracycline resistance operon from
Escherichia coli fused to a human cytomegalovirus min-
imal promoter upstream of a polycloning site and the
simian virus 40 polyadenylation signal. To generate
pUHD10-3VJ1, the 1,059-bp ClaI fragment of the retroviral
construct RCAS-VJ1 (Bos et al., 1990; Hartl and Bister,
1995) containing the v-jun segment that corresponds to
the entire c-jun coding region was treated with the Kle-
now enzyme for blunt-end generation and ligated into
pUHD10-3 that had been digested with EcoRI and filled
in using the Klenow enzyme. The structure of the con-
struct was confirmed by restriction-enzyme analysis and
nucleotide sequencing by the dideoxynucleotide chain-
termination method (Sanger et al., 1977) using a T7
(
t
t
p
c
w
t
1
c
(
p
d
a
b
G
o
1
f
o
108 BADER, HARTL, AND BISTERsequencing kit (Amersham Pharmacia Biotech, Freiburg,
Germany). The v-jun allele in pUHD10-3VJ1 encodes a
295-amino acid, 36-kD protein (p36v-jun) encompassing
the jun-specific carboxyl-terminal 292 amino acids of the
Gag-Jun hybrid protein (p65gag-jun) specified by ASV17
Maki et al., 1987; Bos et al., 1990) and three amino-
erminal residues encoded by the polylinker of the adap-
or plasmid (Hughes et al., 1987; Bos et al., 1990).
Quail JAC cDNA clone QJAC3 was isolated from a
lgt10-based cDNA library constructed from RCAS-VJ1(v-
jun)-transformed QEF as described (Hartl and Bister,
1995), using the 193-bp EcoRI-SphI DNA fragment of
chicken JAC cDNA clone AC01 as a probe. The clone
AC01 was isolated from a cDNA library constructed from
ASV17-transformed CEF (Hartl and Bister, 1998) using a
hybridization probe obtained by subtraction of mRNA/
cDNA preparations from normal versus ASV17-trans-
formed CEF. The nucleotide sequences of quail and
chicken JAC cDNAs have been deposited with the Gen-
Bank database under the accession numbers AF172322
and AF172321, respectively.
Cell culture
Fertile Japanese quail (Coturnix japonica) eggs were
obtained from Hagn Geflu¨gel (Andorf, Austria). Primary
QEF were prepared as described (Vogt, 1969). The fol-
lowing established lines of transformed QEF were used
in this study: VCD, transformed by a chimeric v-jun/c-jun/
junD oncogene (Hartl and Bister, 1995; Hartl et al., 1995);
MH2A10, transformed by the v-myc and v-mil oncogenes
of avian acute leukemia virus MH2 (Jansen et al., 1983);
MH2D12, transformed by the MH2 v-myc oncogene
(Jansen et al., 1985); Q8, transformed by the v-myc onco-
gene of avian acute leukemia virus MC29 (Bister et al.,
1977); QT6, derived from a methylcholanthrene-induced
fibrosarcoma (Moscovici et al., 1977); and R(2)3, trans-
formed by the v-src oncogene of RSV (Bister et al., 1977).
The retroviral constructs RCAS-VJ1 and RCAS-MC29
used for the generation of transformed QEF mass cul-
tures have been described previously (Bos et al., 1990;
Tikhonenko and Lineal, 1992; Hartl and Bister, 1995,
1998). Cells were cultured in medium with or without
doxycycline as described (Oberst et al., 1999).
Soft agar colony assays were carried out as described
previously (Bister et al., 1977; Oberst et al., 1999). Cells
from the lines Q/35 or Q/d3 (see below) containing a
doxycycline-controlled transactivator (tTA) or reverse
transactivator (rtTA), respectively, were divided into two
populations each. One population was incubated in the
absence, the other in the presence of doxycycline for 6
days. Aliquots of these cell cultures containing 0.5, 1, or
2.5 3 105 cells were then suspended in soft agar and
oured onto 35-mm dishes. Where indicated, doxycy-
line was added to the agar at 1 mg/ml. Every 2 or 3 days,
the cells were reoverlayed with 1 ml of soft agar, with or iwithout doxycycline. Colonies were counted after 2 to 3
weeks.
For growth-rate analysis, cells were seeded in 35-mm
dishes at a density of 1.0 or 1.5 3 106 cells per dish in
medium lacking doxycycline for cells expressing the tTA
transactivator, or in medium supplemented with doxycy-
cline for cells expressing the rtTA transactivator, and
then cultivated for 1 day. The next day, the medium was
changed and one half of the dishes was incubated in the
absence, the other half in the presence of doxycycline.
Every 2 days, the medium was renewed. All cell numbers
were determined using cells from three parallel dishes.
DNA transfection and generation of conditionally
transformed cell lines
DNA transfer into secondary QEF was performed as
described (Hartl and Vogt, 1992; Hartl and Bister, 1995;
Oberst et al., 1999). DNA from the plasmids pUHD15-
1neo and pUHD10-3VJ1, or from pUHD17-1neo and
pUHD10-3VJ1, respectively, was cotransfected into 4 3
106 cells per 100-mm dish using 5–20 mg of DNA in 1:1 or
2:1 ratios. Twenty-four hours after transfection, confluent
cells were overlayed with 2 ml of prewarmed (45°C)
bottom agar [Ham’s F-10 nutrient mixture with glutamine
(GIBCO-BRL, Vienna, Austria) supplemented with 0.75%
(w/v) bactoagar (Difco, Vienna, Austria), 0.295% (w/v)
tryptose phosphate both (Difco), 3.5% (v/v) newborn calf
serum (GIBCO-BRL), 1.25% (v/v) heat-inactivated chicken
serum (GIBCO-BRL), 1% (v/v) of a 1003 antibiotic-antimy-
cotic mixture (GIBCO-BRL), 2.5% (v/v) of a 7.5% (w/v)
sodium bicarbonate solution (GIBCO-BRL), 1% (v/v) of a
1003 glutamine solution (GIBCO-BRL), and 1.25% (v/v)
dimethylsulfoxide (Fluka, Vienna, Austria)] in 35-mm
dishes. Doxycycline (1 mg/ml) was included when cells
ere transfected with pUHD17-1neo encoding the rtTA
ransactivator. Between 2 and 3 weeks after transfection,
69 independent foci of morphologically transformed
ells were isolated and propagated in growth medium
Bister et al., 1977; Oberst et al., 1999), supplemented
with doxycycline (1 mg/ml) for cells transfected with
UHD17-1neo. One cell clone (Q/35) containing a tTA-
ependent v-jun allele, and three clones (Q/VII, Q/XXII,
nd Q/d3) containing a rtTA-dependent v-jun allele could
e developed into long-term cell lines.
ene expression analysis
Isolation of mRNA and Northern analysis were carried
ut as described (Hartl and Bister, 1995, 1998; Hartl et al.,
995; Oberst et al., 1999). Northern analysis was per-
ormed using 2 or 5 mg of poly(A)1 RNA selected twice on
ligo(dT) columns (Weiskirchen and Bister, 1993) or 15
mg of total cellular RNAs. The following hybridization
probes were used: the Bsu36I/HincII fragment encom-
passing nucleotides 459–1198 of the chicken c-jun cod-
ng region (Nishimura and Vogt, 1988), the EcoRI insert
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109CONDITIONAL CELL TRANSFORMATION BY v-junfragment of the 620-bp quail BKJ cDNA clone VQ80 (Hartl
and Bister, 1995, 1998), the EcoRI insert fragment of the
560-bp quail JAC cDNA clone QJAC3, and the EcoRI
insert fragment of the 1,213-bp quail glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA clone 67
(Weiskirchen et al., 1993).
Immunoblot analysis was carried out as described
(Hartl et al., 1995; Hartl and Bister, 1998; Oberst et al.,
1999), using 0.45-mm nitrocellulose filters. The Jun-spe-
ific antiserum (used at a dilution of 1:1000) directed
gainst recombinant chicken c-Jun protein was kindly
rovided by Peter K. Vogt (The Scripps Research Insti-
ute, La Jolla, CA).
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